The Latest in Stroke Risk Reduction Strategies: Are Your Patients Protected?

Learn about the role GLP-1 RAs play in stroke risk reduction, especially among patients with type 2 diabetes. Expert faculty review the latest evidence and strategies for individualizing care plans to address patients’ stroke risk through ClinicalThought commentaries, an on-demand webcast with accompanying slides, and a downloadable clinical resource.

Share

Program Content

Activities

Stroke Risk Reduction in Diabetes Care
Stroke Risk Reduction and Outcomes With Novel Therapies in Diabetes Care
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: August 26, 2024

Expires: August 25, 2025

Faculty

cover img faculity

Alejandro A. Rabinstein, MD, FAHA

Professor of Neurology
Chair, Hospital Neurology and Neurocritical Care Division
Mayo Clinic
Rochester, Minnesota

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by an educational grant from Novo Nordisk.

Novo Nordisk